Joseph Caprini/LinkedIn
Nov 15, 2025, 08:19
Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
Joseph Caprini, Senior Clinician Educator at The University of Chicago Pritzker School of Medicine, shared on LinkedIn:
”Just released my UIP 2025 session with Alfonso J. Tafur MD MS MBA RPVI on measuring VTE recurrence risk and tailoring treatment.
Dr. Caprini discusses how to pinpoint patients at greatest risk of VTE recurrence and highlights the value of the Caprini Risk Score in guiding long-term prevention.
He also explains how biomarkers, imaging, clinical history, and practical decision frameworks support more precise assessments and determine when extended prophylaxis is warranted.
Stay updated with Hemostasis Today.
-
Apr 12, 2026, 22:12Maciej Banach: The ‘Metastatic’ Cardiovascular Threat We Can No Longer Ignore
-
Apr 12, 2026, 21:52Umar Jawed: The Most Dangerous Anti-D Result Is Not the Highest One – It’s the One You Underestimate Early
-
Apr 12, 2026, 21:37Demosthenes Panagiotakos: Hellenic Atherosclerosis Society Calls for Papers on Innovative Strategies in Atherosclerotic Plaque Management
-
Apr 12, 2026, 21:24Heghine Khachatryan: Diagnosing PNH in Resource-Limited Settings
-
Apr 12, 2026, 21:15Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
-
Apr 12, 2026, 17:34Caitlin Raymond: Granulocyte Transfusions for the Overworked Fellow
-
Apr 12, 2026, 17:33Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
-
Apr 12, 2026, 17:32Bastu Odoka: Same Blood Group Does Not Guarantee Compatibility
-
Apr 12, 2026, 17:31Jack Hadfield: SARS-CoV-2–Associated Lasting Mitochondrial Injury in Cardiomyocytes